Follow the people · Insider
Elizabeth Yeu Lin
Elizabeth Yeu Lin files insider transactions with the SEC as a chief medical officer of Tarsus Pharmaceuticals (TARS). We hold 5 disclosed purchases and sales filed since 26 January 2021, 2 of them in the last 90 days.
- Files forTARS
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure3 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 31 December 2021 — 2 September 2026Chief Medical Officer · Tarsus Pharmaceuticals (TARS)42 Form 4 lines · source: SEC Form 4
- Filed 21 January 2021 — 18 June 2025Director · Staar Surgical Co (STAA)10 Form 4 lines · source: SEC Form 4
Everything they disclosed
52 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 4,601 shares of Tarsus PharmaceuticalsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- ▼ sold on the open market 5,387 shares of Tarsus PharmaceuticalsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 1,590 shares of Tarsus PharmaceuticalsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 375 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 379 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 390 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 19 March 2026 · filed 19 March 2026
- ▼ sold on the open market 375 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 379 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 390 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 19 March 2026 · filed 19 March 2026
- exercised options over 2,511 shares of Tarsus PharmaceuticalsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 2,511 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 2,511 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 2,511 shares of Tarsus PharmaceuticalsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- was granted 27,310 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Stock Option (right to buy) · traded 5 March 2026 · filed 9 March 2026
- was granted 17,161 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Restricted Stock Units · traded 5 March 2026 · filed 9 March 2026
- was granted 27,310 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Stock Option (right to buy) · traded 5 March 2026 · filed 9 March 2026
- was granted 17,161 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Restricted Stock Units · traded 5 March 2026 · filed 9 March 2026
- exercised options over 6,819 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 December 2025Restricted Stock Units · traded 15 December 2025 · filed 17 December 2025
- exercised options over 6,819 shares of Tarsus PharmaceuticalsSEC Form 417 December 2025Common Stock · traded 15 December 2025 · filed 17 December 2025
- ▼ sold on the open market 2,078 shares of Tarsus PharmaceuticalsSEC Form 417 December 2025Common Stock · traded 16 December 2025 · filed 17 December 2025
- was granted 5,341 shares of Staar Surgical Co (a derivative holding)SEC Form 420 June 2025Restricted Stock Units · traded 18 June 2025 · filed 20 June 2025
- was granted 9,708 shares of Staar Surgical Co (a derivative holding)SEC Form 420 June 2025Common Stock Options · traded 18 June 2025 · filed 20 June 2025
- exercised options over 3,350 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 June 2025Restricted Stock Units · traded 13 June 2025 · filed 17 June 2025
- exercised options over 3,350 shares of Tarsus PharmaceuticalsSEC Form 417 June 2025Common Stock · traded 13 June 2025 · filed 17 June 2025
- ▼ sold on the open market 1,006 shares of Tarsus PharmaceuticalsSEC Form 417 June 2025Common Stock · traded 16 June 2025 · filed 17 June 2025
- was granted 15,314 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 47 March 2025Stock Option (right to buy) · traded 5 March 2025 · filed 7 March 2025
- was granted 10,045 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 47 March 2025Restricted Stock Units · traded 5 March 2025 · filed 7 March 2025
- was granted 41,074 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 46 November 2024Stock Option (right to buy) · traded 4 November 2024 · filed 6 November 2024
- was granted 27,278 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 46 November 2024Restricted Stock Units · traded 4 November 2024 · filed 6 November 2024
- exercised options over 3,350 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 425 June 2024Restricted Stock Units · traded 24 June 2024 · filed 25 June 2024
- exercised options over 3,350 shares of Tarsus PharmaceuticalsSEC Form 425 June 2024Common Stock · traded 24 June 2024 · filed 25 June 2024
- was granted 4,010 shares of Staar Surgical Co (a derivative holding)SEC Form 424 June 2024Common Stock Options · traded 20 June 2024 · filed 24 June 2024
- was granted 2,244 shares of Staar Surgical CoSEC Form 424 June 2024Common Stock · traded 20 June 2024 · filed 24 June 2024
- was granted 5,000 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 414 June 2024Stock Option (right to buy) · traded 13 June 2024 · filed 14 June 2024
- was granted 3,350 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 414 June 2024Restricted Stock Units · traded 13 June 2024 · filed 14 June 2024
- was granted 10,000 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 430 January 2024Stock Option (right to buy) · traded 25 January 2024 · filed 30 January 2024
- ▲ bought on the open market 2,500 shares of Staar Surgical CoSEC Form 422 September 2023Common Stock · traded 21 September 2023 · filed 22 September 2023
- ▲ bought on the open market 9,506 shares of Tarsus PharmaceuticalsSEC Form 417 August 2023Common Stock · traded 15 August 2023 · filed 17 August 2023
- was granted 5,000 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 426 June 2023Stock Option (right to buy) · traded 22 June 2023 · filed 26 June 2023
- was granted 3,350 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 426 June 2023Restricted Stock Units · traded 22 June 2023 · filed 26 June 2023
- exercised options over 2,000 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 421 June 2023Restricted Stock Units · traded 16 June 2023 · filed 21 June 2023
- exercised options over 2,000 shares of Tarsus PharmaceuticalsSEC Form 421 June 2023Common Stock · traded 16 June 2023 · filed 21 June 2023
- exercised options over 6,256 shares of Staar Surgical Co (a derivative holding)SEC Form 416 June 2023Common Stock Options · traded 15 June 2023 · filed 16 June 2023
- ▲ bought on the open market 12,040 shares of Tarsus PharmaceuticalsSEC Form 416 September 2022Common Stock · traded 14 September 2022 · filed 16 September 2022
- ▲ bought on the open market 6,360 shares of Tarsus PharmaceuticalsSEC Form 416 September 2022Common Stock · traded 14 September 2022 · filed 16 September 2022
- was granted 7,000 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 41 July 2022Employee Stock Option (right to buy) · traded 16 June 2022 · filed 1 July 2022
- was granted 2,000 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 41 July 2022Restricted Stock Units · traded 16 June 2022 · filed 1 July 2022
- exercised options over 5,765 shares of Staar Surgical Co (a derivative holding)SEC Form 417 June 2022Common Stock Options · traded 16 June 2022 · filed 17 June 2022
- exercised options over 355 shares of Staar Surgical CoSEC Form 417 June 2022Common Stock · traded 16 June 2022 · filed 17 June 2022
- was granted 20,000 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 44 January 2022Stock Option (right to buy) · traded 31 December 2021 · filed 4 January 2022
- was granted 1,703 shares of Staar Surgical Co (a derivative holding)SEC Form 425 June 2021Common Stock Options · traded 24 June 2021 · filed 25 June 2021
- was granted 1,367 shares of Staar Surgical Co (a derivative holding)SEC Form 426 January 2021Common Stock Options · traded 21 January 2021 · filed 26 January 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.